Virtu Financial LLC Makes New Investment in NuCana plc (NASDAQ:NCNA)

Virtu Financial LLC bought a new stake in NuCana plc (NASDAQ:NCNA) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 40,399 shares of the company’s stock, valued at approximately $48,000. Virtu Financial LLC owned 1.53% of NuCana as of its most recent SEC filing.

NuCana Stock Up 2.0 %

Shares of NCNA stock opened at $0.89 on Wednesday. NuCana plc has a twelve month low of $0.69 and a twelve month high of $10.79. The stock’s fifty day simple moving average is $0.94 and its 200 day simple moving average is $1.43. The firm has a market capitalization of $2.35 million, a P/E ratio of -0.08 and a beta of 0.89.

NuCana (NASDAQ:NCNA) last posted its earnings results on Thursday, March 20th. The company reported ($0.32) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.43) by $2.11. As a group, equities research analysts expect that NuCana plc will post -13.42 EPS for the current fiscal year.

NuCana Company Profile

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company, through its technology, is developing ProTides medicines to overcome the limitations of nucleoside analogs and generate much higher concentrations of anti-cancer metabolites in cancer cells.